Couverture de Rewriting the Narrative of Private Equity in Healthcare

Rewriting the Narrative of Private Equity in Healthcare

Rewriting the Narrative of Private Equity in Healthcare

Écouter gratuitement

Voir les détails

À propos de cette écoute

In this episode of "Counsel That Cares," Healthcare Transactions attorneys David Marks and Eric Scalzo, along with Chartis Strategic Transformation partners Sri Mani and Eric Mayeda, discuss the increasing scrutiny of investor-owned healthcare entities. They note state legislatures and the Federal Trade Commission (FTC) alike have expressed increasing concerns over consolidation's potential negative impacts. Mr. Mani and Mr. Mayeda share insights into how new regulations and rising public skepticism are shaping the healthcare investment environment, emphasizing the need for private equity firms to articulate their value proposition and focus on sustainable, long-term opportunities for growth.

The discussion also seeks to counter some of the negative publicity by highlighting the critical role of private equity in addressing healthcare industry challenges, such as access to care in underserved areas. The speakers argue that a nuanced approach to private capital that recognizes its potential to drive innovation is essential, along with a data-driven narrative that can effectively respond to negative perceptions. As they look toward 2025, the group expresses optimism about the future, suggesting that investment in healthcare is poised to increase, fueled by a commitment to improving patient outcomes and satisfaction.

Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !

    Ce que les auditeurs disent de Rewriting the Narrative of Private Equity in Healthcare

    Moyenne des évaluations utilisateurs. Seuls les utilisateurs ayant écouté le titre peuvent laisser une évaluation.

    Commentaires - Veuillez sélectionner les onglets ci-dessous pour changer la provenance des commentaires.

    Il n'y a pas encore de critique disponible pour ce titre.